Year archive

CLINUVEL PHARMACEUTICALS LIMITED — 2005 filings

All 74 regulatory filings released by CLINUVEL PHARMACEUTICALS LIMITED (CUV) in 2005, sourced directly from the official regulator.

74 Filings

2005 Period

2005 filings (74)

Filing	Released	Lang
Appendix 3B 7 pages ?Kb Regulatory Filings	2005-12-14	English
Company Secretary Appointment 1 page ?Kb Regulatory Filings	2005-12-06	English
Final Director's Interest Notice 3 pages ?Kb Regulatory Filings	2005-11-30	English
Appendix 3B 7 pages ?Kb Regulatory Filings	2005-11-28	English
New Funding of $10m & Restructure of Management 4 pages ?Kb Regulatory Filings	2005-11-27	English
In-licenses rights to sell & distribute Vaniqa 3 pages ?Kb Regulatory Filings	2005-11-15	English
Directors Interests 13 pages ?Kb Regulatory Filings	2005-11-14	English
Ethics approval for pharmacokinetic trial 3 pages ?Kb Regulatory Filings	2005-11-13	English
Company Secretary Changed 1 page ?Kb Regulatory Filings	2005-11-09	English
Appendix 3B/Notice under S 708A(5)(e) 8 pages ?Kb Regulatory Filings	2005-11-08	English
TGA Approval for Zindaclin 3 pages ?Kb Regulatory Filings	2005-11-07	English
Share Purchase Plan Documentation 7 pages ?Kb Regulatory Filings	2005-11-07	English
Open Briefing Epitan MD on PMLE Trials 4 pages ?Kb Regulatory Filings	2005-11-02	English
Commitments Test Entity - First Quarter Report 5 pages ?Kb Regulatory Filings	2005-10-30	English
AGM 2005 Slides 4 pages ?Kb Regulatory Filings	2005-10-27	English
Results of EPT1647 Polymorphous Light Eruption Trial 5 pages ?Kb Regulatory Filings	2005-10-27	English
Results of Annual General Meeting 3 pages ?Kb Regulatory Filings	2005-10-27	English
Appendix 3B: Application for Quotation of Additional Secur. 9 pages ?Kb Regulatory Filings	2005-10-25	English
Topical Patent Filed 3 pages ?Kb Regulatory Filings	2005-10-23	English
Private Placement clarification (Director's shares) 1 Regulatory Filings	2005-10-19	English
Private Placement raises $A6.9m - SPP announced 3 pages ?Kb Regulatory Filings	2005-10-18	English
Topical trial begins in London 5 pages ?Kb Regulatory Filings	2005-10-18	English
Trading Halt 1 page ?Kb Regulatory Filings	2005-10-17	English
Response to The Age press article 1 page ?Kb Regulatory Filings	2005-10-16	English
Notice of Annual General Meeting 21 pages ?Kb Regulatory Filings	2005-10-13	English
Recruitment and dosing completed for photoprotection trial 2 pages ?Kb Regulatory Filings	2005-09-28	English
2005 Annual Report and Accounts 68 pages ?Kb Regulatory Filings	2005-09-25	English
Begins PMLE trial in Melbourne 4 pages ?Kb Regulatory Filings	2005-09-25	English
Chairman Appointment 2 pages ?Kb Regulatory Filings	2005-09-20	English
Investor Presentation September 2005 15 pages ?Kb Regulatory Filings	2005-09-12	English
Change of Director's Interest Notice 2 pages ?Kb Regulatory Filings	2005-09-12	English
Ethics approval for PMLE trial in Melbourne 5 pages ?Kb Regulatory Filings	2005-09-07	English
EGM Results 2 pages ?Kb Regulatory Filings	2005-09-04	English
Preliminary Final Report 41 pages ?Kb Regulatory Filings	2005-08-30	English
Exorex recommended for PBS - ZORAC in-licensed 2 pages ?Kb Regulatory Filings	2005-08-17	English
Open Briefing Epitan Pharmaceutical Business Devt Strategy 3 pages ?Kb Regulatory Filings	2005-08-17	English
Notice of Extraordinary General Meeting 16 pages ?Kb Regulatory Filings	2005-08-04	English
Clinical Manager Retires 2 pages ?Kb Regulatory Filings	2005-08-01	English
Commitments Test Entity - Fourth Quarter Report 5 pages ?Kb Regulatory Filings	2005-07-27	English
Clinical trials to focus on PMLE 5 pages ?Kb Regulatory Filings	2005-07-26	English
Open Briefing EpiTan CEO on PMLE Announcement 6 pages ?Kb Regulatory Filings	2005-07-26	English
Becoming a substantial holder 2 pages ?Kb Regulatory Filings	2005-07-18	English
Response to ASX Query re Share Price 4 pages ?Kb Regulatory Filings	2005-07-13	English
Appendix 3B 8 pages ?Kb Regulatory Filings	2005-07-11	English
Private Placement raises A$3.5 Million 2 pages ?Kb Regulatory Filings	2005-07-06	English
Mariner Corporate Finance Appointed 2 pages ?Kb Regulatory Filings	2005-07-05	English
MCI distributes remainder Epitan shares/Change of Dir. Int's 7 pages ?Kb Regulatory Filings	2005-06-30	English
Endpoint Trial Begins in Sydney 4 pages ?Kb Regulatory Filings	2005-06-13	English
Excellent results from sustained release trial 7 pages ?Kb Regulatory Filings	2005-05-18	English
PSD: PSD & EPT successfully complete first stage of study 2 pages ?Kb Regulatory Filings	2005-05-17	English
EPT & PSD complete first stage of proof of concept study 4 pages ?Kb Regulatory Filings	2005-05-17	English
Change of Director's Interest Notice 2 pages ?Kb Regulatory Filings	2005-05-16	English
Current market conditions unattractive for capital raising 3 pages ?Kb Regulatory Filings	2005-05-10	English
Commitments Test Entity - Third Quarter Report 5 pages ?Kb Regulatory Filings	2005-04-28	English
Results of Meeting 1 page ?Kb Regulatory Filings	2005-04-28	English
Open Briefing EpiTan CEO on Recent Share Price Weakness 4 pages ?Kb Regulatory Filings	2005-04-05	English
Appt of Non-Exec Director/Initial Directors Interest Notice 5 pages ?Kb Regulatory Filings	2005-04-03	English
Change of Director's Interest Notice 3 pages ?Kb Regulatory Filings	2005-03-31	English
To List on AIM/Capital Raising & EGM Notification 17 pages ?Kb Regulatory Filings	2005-03-29	English
Correction to Appendix 3B (4 March 2005) 10 pages ?Kb Regulatory Filings	2005-03-08	English
Receives Ethic Approval for Phase II Endpoint Study-Sydney 3 pages ?Kb Regulatory Filings	2005-03-06	English
Appendix 3B 9 pages ?Kb Regulatory Filings	2005-03-03	English
PMLE trial of Melanotan to start in Finland 3 pages ?Kb Regulatory Filings	2005-02-28	English
Company Secretary Appointed 2 pages ?Kb Regulatory Filings	2005-02-28	English
Change of Director's Interest Notice 2 pages ?Kb Regulatory Filings	2005-02-27	English
Half Yearly Report & Half Yearly Accounts 24 pages ?Kb Regulatory Filings	2005-02-23	English
Files for full international patent for sustained release 2 pages ?Kb Regulatory Filings	2005-02-13	English
In-Licenses OraDisc A from Access Pharmaceuticals USA 2 pages ?Kb Regulatory Filings	2005-02-07	English
Initial Director's Interest Notice 2 pages ?Kb Regulatory Filings	2005-02-01	English
Appoints Regulatory Affairs Manager 2 pages ?Kb Regulatory Filings	2005-01-23	English
UK regulatory appr obtained for topical trial of Melanotan 3 pages ?Kb Regulatory Filings	2005-01-23	English
Open Briefing.EpiTan.CEO/Board Changes & Business Update 4 pages ?Kb Regulatory Filings	2005-01-23	English
Retirement & Appointment of CEO 4 pages ?Kb Regulatory Filings	2005-01-20	English
Commitments Test Entity - Second Quarter Report 5 pages ?Kb Regulatory Filings	2005-01-20	English

Filings by year

2026 21 filings
2025 67 filings
2024 96 filings
2023 62 filings
2022 63 filings
2021 59 filings
2020 69 filings
2019 72 filings
2018 54 filings
2017 32 filings
2016 52 filings
2015 36 filings
2014 59 filings
2013 39 filings
2012 38 filings
2011 47 filings
2010 56 filings
2009 45 filings
2008 43 filings
2007 54 filings
2006 10 filings
2005 74 filings
2004 49 filings
2003 53 filings
2002 2 filings